| 常用名 | Vidofludimus hemicalcium | CAS号 | 1354012-90-0 |
|---|---|---|---|
| 价格 | ¥需询单/100mg ¥需询单/250mg ¥需询单/1g | 纯度 | 98.0% |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Vidofludimus (4sc-101; SC12267) hemicalcium is an orally active inhibitor for dihydroorotate dehydrogenase (DHODH) and also is a novel modulator for farnesoid X receptor (FXR). Vidofludimus hemicalcium, as an immunomodulatory agent, can be used for the research of autoimmune disorders such as inflammatory bowel disease (IBD). Vidofludimus hemicalcium also can be used for the research of fatty liver by targeting FXR[1][2][3]. 物理化学性质: CAS号:1354012-90-0 常用中文名:Vidofludimus hemicalcium 常用英文名:Vidofludimus hemicalcium 分子式:C20H18FNO4.1/2Ca 分子量:375.40 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |